Binding Site Asymmetry in Human Transthyretin: Insights from a Joint Neutron and X-ray Crystallographic Analysis Using Perdeuterated Protein

Overview

Journal IUCrJ

Date 2014 Dec 9

PMID 25485123

Citations 16

Authors

Melina Haupt

Matthew P Blakeley

Stuart J Fisher

Sax A Mason

Jon B Cooper

Edward P Mitchell

V Trevor Forsyth

Affiliations

Soon will be listed here.

Abstract

Human transthyretin has an intrinsic tendency to form amyloid fibrils and is heavily implicated in senile systemic amyloidosis. Here, detailed neutron structural studies of perdeuterated transthyretin are described. The analyses, which fully exploit the enhanced visibility of isotopically replaced hydrogen atoms, yield new information on the stability of the protein and the possible mechanisms of amyloid formation. Residue Ser117 may play a pivotal role in that a single water molecule is closely associated with the γ-hydrogen atoms in one of the binding pockets, and could be important in determining which of the two sites is available to the substrate. The hydrogen-bond network at the monomer-monomer interface is more extensive than that at the dimer-dimer interface. Additionally, the edge strands of the primary dimer are seen to be favourable for continuation of the β-sheet and the formation of an extended cross-β structure through sequential dimer couplings. It is argued that the precursor to fibril formation is the dimeric form of the protein.

Citing Articles

Counter-diffusion studies of human transthyretin: the growth of high-quality crystals for X-ray and neutron crystallography.

DeAth C, Oliva M, Moulin M, Blakeley M, Haertlein M, Mitchell E J Appl Crystallogr. 2025; 58(Pt 1):107-118.

PMID: 39917185 PMC: 11798515. DOI: 10.1107/S1600576724011191.

In silico prediction of the interaction of legacy and novel per- and poly-fluoroalkyl substances (PFAS) with selected human transporters and of their possible accumulation in the human body.

Tiburtini G, Bertarini L, Bersani M, Dragani T, Rolando B, Binello A Arch Toxicol. 2024; 98(9):3035-3047.

PMID: 38884658 PMC: 11324760. DOI: 10.1007/s00204-024-03797-0.

3-O-Methyltolcapone and Its Lipophilic Analogues Are Potent Inhibitors of Transthyretin Amyloidogenesis with High Permeability and Low Toxicity.

Poonsiri T, DellAccantera D, Loconte V, Casnati A, Cervoni L, Arcovito A Int J Mol Sci. 2024; 25(1).

PMID: 38203650 PMC: 10779086. DOI: 10.3390/ijms25010479.

Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis.

Kim B, Ko Y, Si J, Na J, Ortore G, Chiellini G Comput Struct Biotechnol J. 2023; 21:4717-4728.

PMID: 37822560 PMC: 10562617. DOI: 10.1016/j.csbj.2023.09.028.

Structural insights into protein folding, stability and activity using perdeuteration of hen egg-white lysozyme.

Ramos J, Laux V, Haertlein M, Boeri Erba E, McAuley K, Forsyth V IUCrJ. 2021; 8(Pt 3):372-386.

PMID: 33953924 PMC: 8086161. DOI: 10.1107/S2052252521001299.

References

Tomanicek S, Blakeley M, Cooper J, Chen Y, Afonine P, Coates L . Neutron diffraction studies of a class A beta-lactamase Toho-1 E166A/R274N/R276N triple mutant. J Mol Biol. 2009; 396(4):1070-80. DOI: 10.1016/j.jmb.2009.12.036. View

Westermark P, Sletten K, Johansson B, CORNWELL 3rd G . Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A. 1990; 87(7):2843-5. PMC: 53787. DOI: 10.1073/pnas.87.7.2843. View

Serag A, Altenbach C, Gingery M, Hubbell W, Yeates T . Identification of a subunit interface in transthyretin amyloid fibrils: evidence for self-assembly from oligomeric building blocks. Biochemistry. 2001; 40(31):9089-96. DOI: 10.1021/bi010655s. View

Weber I, Waltman M, Mustyakimov M, Blakeley M, Keen D, Ghosh A . Joint X-ray/neutron crystallographic study of HIV-1 protease with clinical inhibitor amprenavir: insights for drug design. J Med Chem. 2013; 56(13):5631-5. PMC: 3815997. DOI: 10.1021/jm400684f. View

Langan P, Forsyth V, Mahendrasingam A, Pigram W, Mason S, Fuller W . A high angle neutron fibre diffraction study of the hydration of the A conformation of the DNA double helix. J Biomol Struct Dyn. 1992; 10(3):489-503. DOI: 10.1080/07391102.1992.10508664. View

Petit-Haertlein I, Blakeley M, Howard E, Hazemann I, Mitschler A, Haertlein M . Perdeuteration, purification, crystallization and preliminary neutron diffraction of an ocean pout type III antifreeze protein. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009; 65(Pt 4):406-9. PMC: 2664773. DOI: 10.1107/S1744309109008574. View

Pepys M . A molecular correlate of clinicopathology in transthyretin amyloidosis. J Pathol. 2008; 217(1):1-3. DOI: 10.1002/path.2467. View

Yokoyama T, Mizuguchi M, Nabeshima Y, Kusaka K, Yamada T, Hosoya T . Hydrogen-bond network and pH sensitivity in transthyretin: Neutron crystal structure of human transthyretin. J Struct Biol. 2012; 177(2):283-90. DOI: 10.1016/j.jsb.2011.12.022. View

Langan P, Sangha A, Wymore T, Parks J, Yang Z, Hanson B . L-Arabinose binding, isomerization, and epimerization by D-xylose isomerase: X-ray/neutron crystallographic and molecular simulation study. Structure. 2014; 22(9):1287-1300. DOI: 10.1016/j.str.2014.07.002. View

10.

Hornberg A, Eneqvist T, Olofsson A, Lundgren E . A comparative analysis of 23 structures of the amyloidogenic protein transthyretin. J Mol Biol. 2000; 302(3):649-69. DOI: 10.1006/jmbi.2000.4078. View

11.

Tanaka I, Kusaka K, Hosoya T, Niimura N, Ohhara T, Kurihara K . Neutron structure analysis using the IBARAKI biological crystal diffractometer (iBIX) at J-PARC. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 11):1194-7. DOI: 10.1107/S0907444910033020. View

12.

Hamilton J, Benson M . Transthyretin: a review from a structural perspective. Cell Mol Life Sci. 2001; 58(10):1491-521. PMC: 11337270. DOI: 10.1007/PL00000791. View

13.

Winn M, Ballard C, Cowtan K, Dodson E, Emsley P, Evans P . Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr. 2011; 67(Pt 4):235-42. PMC: 3069738. DOI: 10.1107/S0907444910045749. View

14.

Choi S, Reixach N, Connelly S, Johnson S, Wilson I, Kelly J . A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity. J Am Chem Soc. 2010; 132(4):1359-70. PMC: 2818972. DOI: 10.1021/ja908562q. View

15.

Nishiyama Y, Langan P, Wada M, Forsyth V . Looking at hydrogen bonds in cellulose. Acta Crystallogr D Biol Crystallogr. 2010; 66(Pt 11):1172-7. DOI: 10.1107/S0907444910032397. View

16.

Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P . Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J Pathol. 2008; 216(2):253-61. DOI: 10.1002/path.2411. View

17.

Kovalevsky A, Hanson L, Fisher S, Mustyakimov M, Mason S, Forsyth V . Metal ion roles and the movement of hydrogen during reaction catalyzed by D-xylose isomerase: a joint x-ray and neutron diffraction study. Structure. 2010; 18(6):688-99. PMC: 2887347. DOI: 10.1016/j.str.2010.03.011. View

18.

Evans P . Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr. 2005; 62(Pt 1):72-82. DOI: 10.1107/S0907444905036693. View

19.

Kovalevsky A, Hanson B, Mason S, Yoshida T, Fisher S, Mustyakimov M . Identification of the elusive hydronium ion exchanging roles with a proton in an enzyme at lower pH values. Angew Chem Int Ed Engl. 2011; 50(33):7520-3. DOI: 10.1002/anie.201101753. View

20.

Connors L, Lim A, Prokaeva T, Roskens V, Costello C . Tabulation of human transthyretin (TTR) variants, 2003. Amyloid. 2003; 10(3):160-84. DOI: 10.3109/13506120308998998. View